Filter
890
Text search:
adverse
drug
reactions
Featured
Recommendations
116
New Publications
260
Language
Document type
No document type
585
Guidelines
144
Studies & Reports
79
Manuals
42
Strategic & Response Plan
13
Fact sheets
11
Training Material
9
Situation Updates
3
Brochures
2
Resource Platforms
1
Infographics
1
Countries / Regions
India
68
Kenya
28
South Africa
27
Ethiopia
26
Tanzania
22
Western and Central Europe
21
Uganda
19
Nigeria
17
Zambia
17
Global
17
Malawi
16
Nepal
15
Ghana
14
Philippines
10
Cambodia
10
Bangladesh
10
Latin America and the Carribbean
10
Eastern Europe
10
Sierra Leone
9
Zimbabwe
9
Liberia
8
Namibia
8
Myanmar / Burma
8
Africa
8
USA
6
Rwanda
6
Botswana
6
Eswatini/ Swaziland
5
South–East Asia Region
5
South Sudan
3
Germany
3
Syria
3
Indonesia
3
Brazil
3
Ukraine
3
Western Pacific Region
3
Congo, Democratic Republic of
2
Haiti
2
Thailand
2
Argentina
2
Colombia
2
Bolivia
2
Lesotho
2
Sri Lanka
2
Asia
2
Timor Leste/ East Timor
2
Russia
2
Cameroon
1
Iraq
1
Lebanon
1
Gambia
1
China
1
Ireland
1
Mozambique
1
Benin
1
Angola
1
West and Central Africa
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Fiji
1
Solomon Islands
1
Bhutan
1
North Korea
1
Laos
1
Australia
1
Georgia
1
Vietnam
1
North America
1
Authors & Publishers
Publication Years
Category
Countries
351
Clinical Guidelines
136
Public Health
43
Women & Child Health
26
Capacity Building
15
Key Resources
12
Pharmacy & Technologies
11
Toolboxes
TB
130
Mental Health
78
HIV
69
Pharmacy
66
COVID-19
35
NTDs
34
AMR
27
Ebola
18
Caregiver
17
NCDs
14
Rapid Response
12
Refugee
10
Polio
8
Conflict
8
Specific Hazards
5
Cholera
4
Natural Hazards
4
Planetary Health
4
Disability
3
Zika
3
Global Health Education
3
Health Financing Toolbox
1
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Update 2017
Document No. : FDA/SMC/SMD/GL-RAR/2013/01
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the dru
...
Revised National Tuberculosis Control Programme
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response
to the Sixty-second World Health Assembly’s resolution on prevention an
...
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
3rd edition
Framework for implementation.
The END TB Strategy.
First Revised Edition
March 2000
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica
...
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an
...